Mežnarić, S.; Belančić, A.; Rački, V.; Vitezić, D.; Mršić-Pelčić, J.; Pilipović, K.
Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy. Biomedicines 2025, 13, 1796.
https://doi.org/10.3390/biomedicines13081796
AMA Style
Mežnarić S, Belančić A, Rački V, Vitezić D, Mršić-Pelčić J, Pilipović K.
Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy. Biomedicines. 2025; 13(8):1796.
https://doi.org/10.3390/biomedicines13081796
Chicago/Turabian Style
Mežnarić, Silvestar, Andrej Belančić, Valentino Rački, Dinko Vitezić, Jasenka Mršić-Pelčić, and Kristina Pilipović.
2025. "Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy" Biomedicines 13, no. 8: 1796.
https://doi.org/10.3390/biomedicines13081796
APA Style
Mežnarić, S., Belančić, A., Rački, V., Vitezić, D., Mršić-Pelčić, J., & Pilipović, K.
(2025). Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy. Biomedicines, 13(8), 1796.
https://doi.org/10.3390/biomedicines13081796